| Stage | ALNY | % of rev | XPO | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.5B | 100.00% | $2.4B | 100.00% | XPO ×1.63 |
| Gross profit | $1.1B | 75.19% | $973M | 41.00% | ALNY +34.2pp |
| Operating income | $346M | 23.72% | $288M | 12.14% | ALNY +11.6pp |
| Pre-tax income | $296M | 20.29% | $240M | 10.11% | ALNY +10.2pp |
| Net income | $2.2B | 148.64% | $181M | 7.63% | ALNY +141.0pp |
| Stage | ALNY | XPO | Gap · A − B |
|---|---|---|---|
| Revenue | $1.5B100.00% | $2.4B100.00% | XPO ×1.63 |
| Gross profit | 75.19%$1.1B | 41.00%$973M | ALNY +34.2pp |
| Operating income | 23.72%$346M | 12.14%$288M | ALNY +11.6pp |
| Pre-tax income | 20.29%$296M | 10.11%$240M | ALNY +10.2pp |
| Net income |
| 148.64%$2.2B |
| 7.63%$181M |
| ALNY +141.0pp |
No shared counterparties.